Genor Biopharma : The latest research data of Lerociclib(GB491) was selected by ASCO Daily News Column, Genor Biopharma's CDK4/6 inhibitor recognized at globe
29 May, 2023 The latest research data of Lerociclib was selected by ASCO Daily News Column, Genor Biopharmas CDK4/6 inhibitor recognized at globe ... | May 30, 2023
United States Binghe Xu Genor Biopharma Chinese Academy Of Medical Sciences Drug Administration Chinese Academy Of Engineering
Source: marketscreener.com